prix cialis le vrai pas le générique viagra prezzi generique viagra belgique farmacie viagra kamagra tadalis viagra rezeptfrei erfahrungen proviagra generique - chere europe viagra cialis serve la ricetta levitra receta medica
cialis generique prix sito sicuro per acquisto viagra super active kamagra oral jelly apotheke viagra tarifs viagra per nachnahme kaufen viagra se vende en farmacias compra levitra comprar cialis em portugal comprar viagra farmacia viagra marche pas

Tag Archive | "cisplatin"

CD4 counts predict chemo response in laryngeal cancer

Sunday, February 26, 2012

0 Comments

Source: www.oncologyreport.com/ Author: Miriam E. Tucker Pretreatment CD4 levels predicted response to induction chemotherapy among 97 patients with advanced laryngeal cancer, but not for 66 patients with advanced oropharyngeal cancer, according to a retrospective analysis of data from two clinical trials. The two groups of head and neck cancer patients were enrolled in two identical […]

Continue reading...

Cisplatin Aids Survival of High-Risk Head and Neck Cancer

Wednesday, February 8, 2012

0 Comments

Source: Oncology Report Adding chemotherapy to radiotherapy improved 10-year survival of resectable head and neck carcinomas among high-risk patients who had microscopically involved resection margins and/or extracapsular spread of disease – but not in high-risk patients who only had tumor in multiple lymph nodes. The findings come from a long-term update and unplanned subset analysis […]

Continue reading...

Cisplatin aids survival of high-risk head and neck cancer

Friday, February 3, 2012

0 Comments

Source: www.oncologyreport.com Author: Miriam E. Tucker Adding chemotherapy to radiotherapy improved 10-year survival of resectable head and neck carcinomas among high-risk patients who had microscopically involved resection margins and/or extracapsular spread of disease – but not in high-risk patients who only had tumor in multiple lymph nodes. The findings come from a long-term update and […]

Continue reading...

Squamous cell subgroups respond differently to treatment

Saturday, January 28, 2012

0 Comments

Source: www.medscape.com Author: Nancy A. Melville A long-term follow-up of patients with head and neck squamous cell carcinoma suggests that only certain high-risk subgroups benefit from radiation plus chemotherapy. This information will spare patients who will not benefit from undergoing the additional treatment. According to the study, presented here at the 2012 Multidisciplinary Head and […]

Continue reading...

Distant Metastases in Head-and-Neck Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy

Tuesday, December 27, 2011

0 Comments

Source: International Journal of Radiation Oncology, Biology and Physics (IJROBP Online) December 2011 PURPOSE: To determine the pattern and risk factors for distant metastases in head-and-neck squamous cell carcinoma (HNSCC) after curative treatment with intensity-modulated radiotherapy (IMRT). METHODS AND MATERIALS: This was a retrospective study of 284 HNSCC patients treated in a single institution with IMRT. […]

Continue reading...

New Therapies and Prognostic Techniques Highlighted in Head and Neck Cancer

Tuesday, October 18, 2011

0 Comments

The Asco Post D. Neil Hayes, MD, MPH, of the University of North Carolina at Chapel Hill, described efforts to position the epidermal growth factor receptor (EGFR) inhibitor cetuximab (Erbitux) in head and neck cancer treatment. Surprisingly negative results came from the phase III Radiation Therapy Oncology Group (RTOG) 0522 trial (N = 940), which showed […]

Continue reading...

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

Tuesday, September 20, 2011

0 Comments

Source: OncologyStat.com TAKE-HOME MESSAGE This randomized, placebo-controlled trial found that weekly palifermin was associated with decreased incidence and duration of severe oral mucositis in patients undergoing postoperative chemoradiotherapy for head and neck cancer. SUMMARY OncologySTAT Editorial Team Combined chemoradiotherapy (CRT) offers improved outcomes after resection of locally advanced head and neck cancer but also increases […]

Continue reading...

New Study Shows that Fatty Acids Reduces Effectiveness of Chemotherapy

Tuesday, September 13, 2011

0 Comments

Source: Medicalexpress.com Researchers at University Medical Center Utrecht, the Netherlands, have discovered a substance that has an adverse effect on nearly all types of chemotherapy – making cancer cells insensitive to the treatment. Chemotherapy often loses effectiveness over time. It is often unclear how or why this happens. It now appears that chemotherapy is made […]

Continue reading...

Collaboration of major biomedical centers has shown convergence on a cellular process for head and neck cancers

Tuesday, August 2, 2011

0 Comments

Source: www.rxpgnews.com Author: Broad Institute of MIT and Harvard Powerful new technologies that zoom in on the connections between human genes and diseases have illuminated the landscape of cancer, singling out changes in tumor DNA that drive the development of certain types of malignancies such as melanoma or ovarian cancer. Now several major biomedical centers […]

Continue reading...

Palifermin reduces severe mucositis in head and neck cancer

Sunday, July 3, 2011

0 Comments

Source: http://www.medscape.com/ Author: Janis C. Kelly Palifermin (Kepivance), which is currently approved for preventing mucositis associated with total-body irradiation and stem-cell transplantation in hematologic malignancies, also prevents oral mucositis in patients with head and neck cancer undergoing radiation and chemotherapy, according to 2 randomized trials published online June 13 in the Journal of Clinical Oncology. […]

Continue reading...